title: Prevention of cytomegalovirus disease after heart transplantation: preemptive therapy with 7 days' intravenous ganciclovir.
authors.affiliation: Programa de Trasplante Cardiaco, Hospital Juan Canalejo, Instituto Universitario Ciencias de la Salud, Universidad de A Coruña, Spain. Maria_Paniagua@canalejo.org
authors.forename: M J
authors.initials: MJ
authors.lastname: Paniagua
authors.forename: M G
authors.initials: MG
authors.lastname: Crespo-Leiro
authors.forename: L
authors.initials: L
authors.lastname: De la Fuente
authors.forename: T
authors.initials: T
authors.lastname: Tabuyo
authors.forename: I
authors.initials: I
authors.lastname: Mosquera
authors.forename: A
authors.initials: A
authors.lastname: Cañizares
authors.forename: C
authors.initials: C
authors.lastname: Naya
authors.forename: P
authors.initials: P
authors.lastname: Fariña
authors.forename: A
authors.initials: A
authors.lastname: Juffé
authors.forename: A
authors.initials: A
authors.lastname: Castro-Beiras
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use*; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control / Q000821:virology*; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D015774:Ganciclovir